January 23, 2018 at 9:00PM EDT - Recording Available
Much has changed in the treatment landscape of non-small cell lung cancer (NSCLC) over the last few years.
January 16, 2018 at 4:00PM CET (Central European Time) - Recording Available
There has been a proliferation of liquid biopsy tests in the last few years. A range of tests are now available, from single mutation assays to sequencing panels of multiple genes.
January 11, 2018 at 9:00 P.M. EST - Recording Available
For the past four decades, advances of any nature in the management of small cell lung cancer (SCLC) have been elusive, and the grim prognosis for patients diagnosed with this disease remained unchanged.
December 20, 2017 at 7:00PM CET (Central European Time) - Recording Available
This webinar will address what is occurring in the field of smoking cessation.
December 6, 2017 at 9:00 P.M. EST - Recording Available
This program will provide an update of current standards of therapy for first- and second line treatment of extensive-stage small cell lung cancer (SCLC).
Monday, December 4, 2017 1:00PM EST / 11:00AM MST/ 7:00PM CET - Recording Available
This program will examine current treatment standards for stage III non-small cell lung cancer (NSCLC).
Wednesday November 15, 2017 12:00PM EST / 10:00AM MDT / 6:00PM CET - Recording Available
This webinar will review selected presentations made at the 2017 ASTRO Annual Meeting that address the evolving role of radiation therapy in the treatment of lung malignancies.
Thursday, November 9, 2017 at 9:00PM EST - Recording Available
The IASLC Atlas of PD-L1 Immunohistochemistry Testing in Lung Cancer is a new resource for understanding programmed cell death ligand-1 (PD-L1) immunohistochemistry (IHC) assays.
October 10, 2017 at 9:00PM EDT - Recording Available
Classification of NSCLC has been rapidly evolving, owing in large part to increased attention to histologic features and common molecular alterations.
October 9, 2017 at 7:00PM CEST - Recording Available
This webinar will highlight advances in the management of lung cancer reported during the recent European Society for Medical Oncology Congress ( ESMO 2017).